DUTASTERIDE
Substance profile for UNII O0J6XJN02I, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 6918296Substance Identity#
- UNII
- O0J6XJN02I
- Preferred term
- DUTASTERIDE
- Registry number
- 164656-23-9
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C27H30F6N2O2
Chemical And Database Identifiers#
- InChIKey
- JWJOTENAMICLJG-QWBYCMEYSA-N
- SMILES
- C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
- RxCUI
- 228790
- PubChem
- 6918296
- NCIt
- C47503
- INN ID
- 7586
DailyMed Socrata Ingredients#
Type, DailyMed label, SPL version table| Type | DailyMed label | SPL version |
|---|
| ACTIVE MOIETY | These highlights do not include all the information needed to use DUTASTERIDE safely and effectively. See full prescribing information for DUTASTERIDE. DUTASTERIDE (dutasteride) soft gelatin capsules Initial U.S. Approval: 2001 | 1 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use DUTASTERIDE safely and effectively. See full prescribing information for DUTASTERIDE. DUTASTERIDE (dutasteride) soft gelatin capsules Initial U.S. Approval: 2001 | 1 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use JALYN safely and effectively. See full prescribing information for JALYN. JALYN (dutasteride and tamsulosin hydrochloride) Capsules Initial U.S. Approval: 2010 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use JALYN safely and effectively. See full prescribing information for JALYN. JALYN (dutasteride and tamsulosin hydrochloride) Capsules Initial U.S. Approval: 2010 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin Capsules Initial U.S. Approval: 2001 | 2 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin Capsules Initial U.S. Approval: 2001 | 2 |
| ACTIVE MOIETY | AVODART (DUTASTERIDE) CAPSULE, LIQUID FILLED [LAKE ERIE MEDICAL & SURGCIAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3766 |
| ACTIVE INGREDIENT | AVODART (DUTASTERIDE) CAPSULE, LIQUID FILLED [LAKE ERIE MEDICAL & SURGCIAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3766 |
| ACTIVE INGREDIENT | AVODART (DUTASTERIDE) CAPSULE, LIQUID FILLED [GLAXOSMITHKLINE LLC] | 21 |
| ACTIVE MOIETY | AVODART (DUTASTERIDE) CAPSULE, LIQUID FILLED [GLAXOSMITHKLINE LLC] | 21 |
| ACTIVE INGREDIENT | JALYN (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE) CAPSULE [GLAXOSMITHKLINE LLC] | 14 |
| ACTIVE MOIETY | JALYN (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE) CAPSULE [GLAXOSMITHKLINE LLC] | 14 |
| ACTIVE MOIETY | DUTASTERIDE CAPSULE [ACTAVIS PHARMA, INC.] | 10 |
| ACTIVE INGREDIENT | DUTASTERIDE CAPSULE [ACTAVIS PHARMA, INC.] | 10 |
| ACTIVE INGREDIENT | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES) CAPSULE [PAR PHARMACEUTICAL] | 7 |
| ACTIVE MOIETY | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES) CAPSULE [PAR PHARMACEUTICAL] | 7 |
| ACTIVE MOIETY | DUTASTERIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 |
| ACTIVE INGREDIENT | DUTASTERIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 |
| ACTIVE MOIETY | DUTASTERIDE CAPSULE, LIQUID FILLED [APOTEX CORP.] | 2 |
| ACTIVE INGREDIENT | DUTASTERIDE CAPSULE, LIQUID FILLED [APOTEX CORP.] | 2 |
| ACTIVE MOIETY | BAKUMOKON 5% MINOXIDIL (MINOXIDIL, DUTASTERIDE, OXYTOCIN) LIQUID [DS LABORATORIES, INC.] | 1 |
| ACTIVE INGREDIENT | BAKUMOKON 5% MINOXIDIL (MINOXIDIL, DUTASTERIDE, OXYTOCIN) LIQUID [DS LABORATORIES, INC.] | 1 |
| ACTIVE MOIETY | BAKUMOKON 7% MINOXIDIL SULFATE (MINOXIDIL SULFATE, DUTASTERIDE, OXYTOCIN) LIQUID [DS LABORATORIES, INC.] | 1 |
| ACTIVE INGREDIENT | BAKUMOKON 7% MINOXIDIL SULFATE (MINOXIDIL SULFATE, DUTASTERIDE, OXYTOCIN) LIQUID [DS LABORATORIES, INC.] | 1 |
| ACTIVE INGREDIENT | DUTASTERIDE (DUTASTERIDE) CAPSULE [AVKARE, INC.] | 1 |
| ACTIVE MOIETY | DUTASTERIDE (DUTASTERIDE) CAPSULE [AVKARE, INC.] | 1 |
| ACTIVE INGREDIENT | DUTASTERIDE CAPSULE [BRECKENRIDGE PHARMACEUTICAL, INC.] | 1 |
| ACTIVE MOIETY | DUTASTERIDE CAPSULE [BRECKENRIDGE PHARMACEUTICAL, INC.] | 1 |
| ACTIVE MOIETY | DUTASTERIDE CAPSULE [ROXANE LABORATORIES, INC.] | 1 |
| ACTIVE INGREDIENT | DUTASTERIDE CAPSULE [ROXANE LABORATORIES, INC.] | 1 |
| ACTIVE MOIETY | DUTASTERIDE CAPSULE, LIQUID FILLED [GLAXOSMITHKLINE LLC] | 1 |
| ACTIVE INGREDIENT | DUTASTERIDE CAPSULE, LIQUID FILLED [GLAXOSMITHKLINE LLC] | 1 |
| ACTIVE INGREDIENT | DUTASTERIDE CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] | 1 |
| ACTIVE MOIETY | DUTASTERIDE CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] | 1 |
pubchem.ncbi.nlm.nih.gov/compound/6918296
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=228790
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47503
precision.fda.gov/uniisearch/srs/unii/O0J6XJN02I